Aliaxin® GP Global Performance – All-round filler for balance, structure and radiance
Aliaxin® GP Global Performance is a versatile hyaluronic acid filler designed to improve skin structure, restore volume and create harmonious facial balance. The product is part of the Aliaxin® series from IBSA Derma, which is known for its fillers with high tissue compatibility and natural integration.
Thanks to its balanced viscosity and elasticity, Aliaxin® GP is suitable for both superficial corrections and deeper treatments, making it an ideal “all-round filler” for the entire face.
What is Aliaxin® GP Global Performance?
Aliaxin® GP contains:
Cross-linked hyaluronic acid – with medium viscosity for both volume and structure
IBSA’s patented HA technology – provides natural tissue integration and long-lasting effect
Biocompatible formulation – minimizes the risk of swelling and provides a soft, natural result
The product is CE marked and developed for global improvement of facial contours, symmetry and skin quality.
Areas of use
-Mid-face zone – for restored volume and radiance
-Cheeks and temples – improves fullness and shape
-Nasolabial folds and corners of the mouth – for smoother and softer transitions
-Chin and jawline – for discreet contouring and balance
How is the treatment done?
Performed by medically trained personnel
Injected into medium to deep dermis depending on area
The treatment takes approximately 20–30 minutes
Results: natural improvement in volume, structure and skin tone immediately after treatment
The effect lasts for 8–12 months, depending on individual factors
Side effects and safety
Aliaxin® GP is CE marked, biocompatible and clinically tested. Possible side effects are mild and transient:
-Redness
-Slight swelling
-Small bruises
Symptoms usually disappear within 1–3 days.
Benefits of Aliaxin® GP Global Performance
✔ All-round filler for the entire face
✔ Improves structure, volume and symmetry
✔ Natural tissue integration and smooth application
✔ Soft, harmonious and long-lasting results
✔ CE-marked and clinically documented safety